Overview

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

Status:
COMPLETED
Trial end date:
2023-07-04
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo/positive drug parallel controlled design was used to evaluate the preliminary efficacy and safety of intravenous infusion of LPM3480392 injection using different dosing regimens in subjects with moderate to severe pain after abdominal surgery.
Phase:
PHASE2
Details
Lead Sponsor:
Luye Pharma Group Ltd.